M

Monogram Orthopaedics Inc
NASDAQ:MGRM

Watchlist Manager
Monogram Orthopaedics Inc
NASDAQ:MGRM
Watchlist
Price: 5.29 USD -0.56%
Market Cap: 191.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+28%
Revenue
Forecast
+41%
Operating Income
Forecast
+58%
Net Income
Forecast
+63%

Wall Street
Price Targets

MGRM Price Targets Summary
Monogram Orthopaedics Inc

Wall Street analysts forecast MGRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MGRM is 5.81 USD with a low forecast of 5.45 USD and a high forecast of 6.3 USD.

MGRM Lowest Forecast
Wall Street Target
5.45 USD
3% Upside
MGRM Average Forecast
Wall Street Target
5.81 USD
10% Upside
MGRM Highest Forecast
Wall Street Target
6.3 USD
19% Upside
Lowest
Price Target
5.45 USD
3% Upside
Average
Price Target
5.81 USD
10% Upside
Highest
Price Target
6.3 USD
19% Upside
Monogram Orthopaedics Inc Competitors:
Price Targets
MEDX
Medmix Ltd
78% Upside
300896
Imeik Technology Development Co Ltd
19% Upside
S
STIL
Stille AB
30% Upside
7817
Paramount Bed Holdings Co Ltd
3% Upside
MEDX
Medmix Ltd
78% Upside
300896
Imeik Technology Development Co Ltd
19% Upside
S
STIL
Stille AB
30% Upside
7817
Paramount Bed Holdings Co Ltd
3% Upside
AVON
Avon Protection PLC
8% Downside
MOVE
Medacta Group SA
4% Upside
PRM
Prim SA
39% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
27% Upside

Revenue
Forecast

Revenue Estimate
Monogram Orthopaedics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Monogram Orthopaedics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Monogram Orthopaedics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
MGRM intrinsic value, competitors valuation, and company profile.
DCF Valuation
MGRM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MGRM stock valuation using valuation multiples.
Wall Street Estimates
MGRM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MGRM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MGRM's stock price target?
Price Target
5.81 USD

According to Wall Street analysts, the average 1-year price target for MGRM is 5.81 USD with a low forecast of 5.45 USD and a high forecast of 6.3 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 276,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.